Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of the National Cancer Institute

• Publication date

  2011-09-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/jnci/djr237PMID 21747048PMCID PMC3168937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New CYP2A6 gene deletion and conversion variants in a population of Black African descent.

  2010cited by this paper
• Sequence variants at CHRNB 3 – CHRNA 6 and CYP 2 A 6 affect smoking behavior

  2010cited by this paper
• Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended‐Duration Transdermal Nicotine Therapy

  2010cited by this paper
• Genome-wide meta-analyses identify multiple loci associated with smoking behavior

  2010cited by this paper
• Sequence variants at CHRNB3–CHRNA6 and CYP2A6 affect smoking behavior

  2010cited by this paper
• Nicotine addiction and nicotinic receptors: lessons from genetically modified mice

  2010cited by this paper
• Light and intermittent smokers: background and perspective.

  2009cited by this paper
• Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

  2009cited by this paper
• Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: recent progress and emerging open questions

  2009cited by this paper
• Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20

  2008cited by this paper
• Trends in cigarette smoking: the Minnesota Heart Survey, 1980-1982 through 2000-2002.

  2008cited by this paper
• A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

  2008cited by this paper
• A variant associated with nicotine dependence, lung cancer and peripheral arterial disease

  2008cited by this paper
• Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.

  2008cited by this paper
• Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

  2008cited by this paper
• Progress and challenges in selected areas of tobacco carcinogenesis.

  2008cited by this paper
• The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer.

  2008cited by this paper
• CYP2A6 polymorphisms and risk for tobacco-related cancers.

  2008cited by this paper
• Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.

  2007cited by this paper
• Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers.

  2007cited by this paper
• Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells

  2006cited by this paper
• CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

  2006cited by this paper
• Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence

  2005cited by this paper
• Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer.

  2005cited by this paper
• Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.

  2004cited by this paper
• A myeloperoxidase polymorphism associated with reduced risk of lung cancer.

  2002cited by this paper
• Trends in cigarette smoking: the Minnesota Heart Survey, 1980 through 1992.

  1998cited by this paper
• Models of interaction between metabolic genes and environmental exposure in cancer susceptibility.

  1998cited by this paper
• Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.

  1997cited by this paper

• A phenome-wide association study of genetically determined nicotine metabolism reveals novel links with health-related outcomes

  2025cites this paper
• Bidirectional Mendelian randomization and immune cell mediation analysis: A STROBE-MR study unveiling the causal link between non-small cell and small cell lung cancers

  2025cites this paper
• A blood- and brain-based EWAS of smoking

  2025cites this paper
• Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation

  2025cites this paper
• Extending Investigations of miR‐126‐5p on the Regulation of CYP2A6, the Major Nicotine‐Inactivating Enzyme

  2025cites this paper
• CYP2A6 and CYP2A13 Genetic Variants are Associated with Decreased Risk of Esophageal Squamous Cell Carcinoma- A Case-control Study Based Assessment

  2025cites this paper
• PharmVar GeneFocus: CYP2A6

  2024cites this paper
• Interaction between Continuous Pack-Years Smoked and Polygenic Risk Score on Lung Cancer Risk: Prospective Results from the Framingham Heart Study

  2024cites this paper
• Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees

  2023cites this paper
• Early Developmental Risks for Tobacco Addiction: A Probabilistic Epigenesis Framework.

  2023cites this paper
• CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian Randomization study

  2023influential citation
• Influence of CYP2A6 genetic variation, nicotine dependence severity, and treatment on smoking cessation success.

  2023cites this paper
• Socioeconomic Status, Smoking, and Lung Cancer: Mediation and Bias Analysis in the SYNERGY Study

  2023cites this paper
• Genotyping, characterization, and imputation of known and novel CYP2A6 structural variants using SNP array data

  2023cites this paper
• A Phenome-wide association study of a genetic score for the nicotine metabolite ratio

  2023cites this paper
• Genetic variability in the neurobiology of nicotine dependence: effects on smoking behavior

  2023cites this paper
• Identification of Sociodemographic, Clinical, and Genetic Factors to Aid Alaska Native and American Indian People to Successfully Quit Smoking.

  2023cites this paper
• Associating CYP2A6 structural variants with ovarian and lung cancer risk in the UK Biobank: replication and extension

  2023cites this paper
• Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation

  2022cites this paper
• Exploring Potential for a Personalized Medicine Approach to Smoking Cessation With an American Indian Tribe

  2022cites this paper
• Effects ofGeneticVariants in theNicotineMetabolismPathwayon Smoking Cessation

  2022cites this paper
• Lung Cancer in the Course of COPD-Emerging Problems Today

  2022cites this paper
• Genetics and Epigenetics of Addiction

  2021cites this paper
• Biochemistry of nicotine metabolism and its relevance to lung cancer

  2021cites this paper
• Impact Of Cyp2a6 Activity On Nicotine Reinforcement And Cue-Reactivity In Daily Smokers.

  2021cites this paper
• Nicotine Addiction: Translational Insights from Circuit Neuroscience.

  2021cites this paper
• Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes

  2021cites this paper
• University of Groningen Postnatal Smoke Exposure Further Increases the Hepatic Nicotine Metabolism in Prenatally Smoke Exposed Male Offspring and Is Linked with Aberrant Cyp2a5 Methylation Lkhagvadorj,

  2021cites this paper
• Diagnosis of Acute Myeloid Leukaemia Using Machine Learning

  2021cites this paper
• Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent

  2020cites this paper
• Postnatal Smoke Exposure Further Increases the Hepatic Nicotine Metabolism in Prenatally Smoke Exposed Male Offspring and Is Linked with Aberrant Cyp2a5 Methylation

  2020cites this paper
• Transferability of Ancestry‐Specific and Cross‐Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations

  2020cites this paper
• The Influence of Tobacco Smoke/Nicotine on CYP2A Expression in Human and African Green Monkey Lungs

  2020cites this paper
• New Biological Insights into Smoking Cessation

  2020cites this paper
• Genetics of Smoking Behaviors in American Indians

  2020influential citation
• Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity

  2020cites this paper
• Stability in effects of different smoking-related polygenic risk scores over age and smoking phenotypes.

  2020cites this paper
• Association between CYP2A6 genotypes and smoking behavior in Lebanese smokers

  2020cites this paper
• Lung Cancer: Genetic Susceptibility

  2020cites this paper
• Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity

  2020cites this paper
• [Bronchial carcinoma and tobacco: An update].

  2019cites this paper
• The Novel CYP2A6 Inhibitor, DLCI-1, Decreases Nicotine Self-Administration in Mice

  2019cites this paper
• Pharmacogenetics and Smoking Cessation

  2019cites this paper
• Not all smokers appear to seek nicotine for the same reasons: implications for preclinical research in nicotine dependence

  2019cites this paper
• Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.

  2019cites this paper
• Pharmacogenomics of nicotine metabolism: novel CYP2A6 and CYP2B6 genetic variation patterns in Alaska Native and American Indian populations.

  2019cites this paper
• Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults

  2019cites this paper
• Phenotypic Annotation: Using Polygenic Scores to Translate Discoveries From Genome-Wide Association Studies From the Top Down

  2019cites this paper
• Relationships Between Smoking Behaviors and Cotinine Levels Among Two American Indian Populations With Distinct Smoking Patterns

  2018cites this paper
• Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women

  2018cites this paper
• P450 Pharmacogenetics in Indigenous North American Populations

  2018cites this paper
• Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism

  2018cites this paper
• Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease

  2018cites this paper
• Genome‐wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences

  2018cites this paper
• Defining Substance Use Disorders: The Need for Peripheral Biomarkers.

  2018cites this paper
• CYP2A6 gene variants may explain smoking status in a Turkish cohort

  2018cites this paper
• Kynurenine 3-Monooxygenase Gene Associated With Nicotine Initiation and Addiction: Analysis of Novel Regulatory Features at 5′ and 3′-Regions

  2018cites this paper
• Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.

  2018cites this paper
• Involvement of Variants in Gene Clusters CHRNA5/A3/B4 on Chromosome 15 to Smoking Behaviors and Lung Cancer

  2018cites this paper
• Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers

  2018cites this paper
• Cigarette consumption and biomarkers of nicotine exposure during pregnancy and postpartum

  2018cites this paper
• Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers

  2018cites this paper
• Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment

  2018cites this paper
• Association of genetic polymorphisms CYP2A6*2 rs1801272 and CYP2A6*9 rs28399433 with tobacco-induced lung Cancer: case-control study in an Egyptian population

  2018cites this paper
• Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real‐world settings? A prospective study

  2018cites this paper
• Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans

  2017cites this paper
• Pharmacogenetic Optimization of Smoking Cessation Treatment.

  2017cites this paper
• Interaction between cytochrome P450 2A6 and Catechol-O-Methyltransferase genes and their association with smoking risk in young men

  2017cites this paper
• Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction

  2017cites this paper
• “Gestaltomics”: Systems Biology Schemes for the Study of Neuropsychiatric Diseases

  2017cites this paper
• Variation in CYP2A6 Activity and Personalized Medicine

  2017cites this paper
• Nicotine Metabolism and Smoking: Ethnic Differences in the Role of P450 2A6.

  2017cites this paper
• Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study

  2017cites this paper
• CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study

  2017cites this paper
• Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer

  2017cites this paper
• Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors

  2017cites this paper
• Study on polymorphisms in CHRNA5/CHRNA3/CHRNB4 gene cluster and the associated with the risk of non-small cell lung cancer

  2017cites this paper
• Role of Non-Coding Genetic Risk Variation in CHRNA5-CHRNA3-CHRNAB4 Cluster on Chromosome 15q21 in Addiction, Lung Cancer, Learning and Memory

  2017cites this paper
• Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies

  2017cites this paper
• Sources of Variation in Nicotine Metabolism and Associations with Smoking Abstinence in Adolescents and Adults

  2016cites this paper
• Application of the PEN-3 Model to Tobacco Initiation, Use, and Cessation Among American Indian and Alaska Native Adults

  2016cites this paper
• Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity

  2016cites this paper
• Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.

  2016cites this paper
• Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study

  2016cites this paper
• The Oncogenic Functions of Nicotinic Acetylcholine Receptors

  2016cites this paper
• Variation in CYP2A6 and tobacco dependence throughout adolescence and in young adult smokers.

  2016cites this paper
• Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers.

  2016cites this paper
• Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio

  2016cites this paper
• Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population

  2016cites this paper
• CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms.

  2016cites this paper
• Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries

  2016cites this paper
• Genetics of Substance Use Disorders.

  2016cites this paper
• Application of a pharmacokinetic/pharmacogenetic approach to assess the nicotine metabolic profile of smokers in the real-life setting.

  2016cites this paper
• Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice.

  2016cites this paper
• Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.

  2016cites this paper
• Common single nucleotide variants underlying drug addiction: more than a decade of research

  2015cites this paper
• Resting‐state functional connectivity and nicotine addiction: prospects for biomarker development

  2015cites this paper
• CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.

  2015cites this paper
• Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking

  2015cites this paper
• Pharmacogenetics of nicotine and associated smoking behaviors.

  2015cites this paper